Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine

Indian Journal of Ophthalmology

Volumn 61, Issue 4, 2013, Pages 168-171

  Ulviye, Yigit ^a   Betul, Tugcu ^a   Nur, Tarakcioglu ^a   Selda, Celik ^a  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hydroxychloroquine; optical coherence tomography; retinal thickness; retinal toxicity

Indexed keywords

ANTIRHEUMATIC AGENT; HYDROXYCHLOROQUINE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA; RETINA DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; DRUG MONITORING; EARLY DIAGNOSIS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETINA; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84878887747     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.112161     Document Type: Article

References (25)

1. Rynes RI. Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 1997;36:799-805.
2. Wolfe F, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken)2010;62:775-84.
3. Ruther K, Foerster J, Berndt S, Schroeter J. Chloroquine/ hydroxychloroquine: Variability of retinotoxic cumulative doses. Ophthalmologe 2007;104:875-9.
4. Turgut B, Turkcuoglu P, Serdar Koca S, Aydemir O. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.Clin Rheumatol 2009;28:607-9.
5. Michaelides M, Stover NB, Francis PJ, Weleber RG. Retinal toxicity associated with hydroxychloroquine and chloroquine: Risk factors, screening, and progression despite cessation of therapy.Arch Ophthalmol 2011;129:30-9.
6. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest ophthalmol Vis Sci 1978;17:1158-75.
7. Hallberg A, Naeser P, Andersson A. Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophtalmol 1990;68:125-30.
8. Kuhn H, Keller P, Kovács E, Steiger A. Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1981;216:177-90.
9. Duncker G, Bredehorn T. Chloroquine-induced lipidosis in the rat retina: Functional and morphological changes after withdrawal of the drug.Graefes Arch Clin Exp Ophthalmol 1996;234:378-81.
10. Kimberly E, Han DP, Schell J, Godara P, Rha J, Carroll J. Spectraldomain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc 2009;107:28-33.
11. Easterbrook M. Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 1992;27:237-39.
12. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF;American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118:415-22.
13. Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond) 2010;245:756-62.
14. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye 2010;24:340-46.
15. Lai TY, Chan WM, Li H, Lai RY, Lam DS. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 2005;1405:794-807.
16. Maturi RK, Yu M, Weleber RG.Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.Arch Ophthalmol 2004;1227:973-81.
17. Moschos MN, Moschos MM, Apostolopoulos M, Mallias JA, Bouros C, Theodossiadis GP. Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 2004;1081:47-53.
18. Rodriguez-Padilla JA, Hedges TR 3 rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-80.
19. Browning DJ. Hydroxychloroquine and chloroquine retinopathy: Screening for drug toxicity. Am J Ophthalmol 2002;1335:649-56.
20. Lyons JS, Severns ML. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 2007;143:801-9
21. Lyons JS, Severns ML.Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: A review: Review of mfERG ring ratios in Plaquenil toxicity. Doc Ophthalmol 2009;118:29-36.
22. Kellner U, Kellner S, Weinitz S. Chloroquine retinopathy: Lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 2008;1162:119-27.
23. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 2012;1304:461-9.
24. Korah S, Kuriakose T. Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 2008;566:511-3.
25. Kelmenson AT, Brar VS, Murthy RK, Chalam KV. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy. Eur J Ophthalmol 2010;204:785-8.